Charles River Laboratories Executive Compensation
Charles River Laboratories is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Charles River Laboratories discloses FY2025 compensation for 2 named executive officers, totaling $14.4M. James C. Foster, the President Chief Executive Officer and Director, accounts for 73% of that combined total.
James C. Foster's total compensation fell 1% year-over-year, from $10.6M in FY2024 to $10.5M in FY2025.
Cash compensation (salary plus bonus) made up 84% of Charles River Laboratories's FY2025 tracked executive pay, with stock awards accounting for 16%.
Among 78 other Healthcare companies in this dataset, Charles River Laboratories's combined tracked executive pay of $14.4M ranks in the 53th percentile (industry median: $12.5M). Its highest-paid executive, James C. Foster, ranks in the 62th percentile for top-executive pay in the sector (industry median: $6.0M).